Oxycodone

Articles · Medicine Compliance Aid Stability · Lactation Safety Information ·

414984009

Articles

Medicine Compliance Aid Stability

OxyNorm · Napp Pharmaceuticals Ltd

Napp Pharmaceuticals Ltd
OxyNorm
Capsules - various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
11th May 2015

Oxycontin · Napp Pharmaceuticals Ltd

Napp Pharmaceuticals Ltd
Oxycontin
Tablets f/c, m/r various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Airtight container.
11th May 2015

Targinact · Napp Pharmaceuticals Ltd

Napp Pharmaceuticals Ltd
Targinact
Tablets f/c, m/r - various strengths
A3 · Amber 3 · No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Airtight container and protect from light
11th May 2015

Lactation Safety Information

Oral / Parenteral

Oral / Parenteral
Dihydrocodeine, Morphine or other appropriate analgesic
Includes combinations with naloxone
Dose-dependent sedation has occurred in breastfed infants
Doses greater than 40mg/day should be avoided in breast feeding mothers
Oxycodone elimination in young infants is both variable and decreased
Avoid in neonates and monitor young infants (see summary)